尿液细胞外囊泡MMP-7可识别常染色体显性多囊肾病快速进展
本研究旨在寻找常染色体显性多囊肾病(ADPKD)快速疾病进展的尿液细胞外囊泡(uEV)标志物。通过蛋白质组学发现uEV中基质金属蛋白酶-7(MMP-7)在快速进展患者中显著升高,并在独立队列中验证;全尿ELISA未显示差异。单核RNA测序显示ADPKD组织中MMP-7在近端小管和髓袢升支粗段细胞高表达,提示uEV-MMP-7是ADPKD快速进展的生物学合理标志物。
要点
- uEV-MMP-7在ADPKD快速进展患者中显著升高,而全尿MMP-7无差异。
- ADPKD组织中MMP-7在近端小管和髓袢升支粗段细胞高表达。
- uEV-MMP-7有望作为ADPKD快速进展的早期标志物。
核心结论
- ADPKD快速进展患者uEV相关MMP-7水平更高,MMP-7是生物学合理的快速进展标志物。
研究设计与样本
- 从两个独立ADPKD队列中形成6组配对病例对照(每组n=10-59),按年龄、性别、总肾脏体积和遗传变异匹配。
- 通过质谱发现候选uEV标志物,并用免疫印迹和ELISA进一步分析。
- 利用健康与ADPKD组织的单核RNA测序确定uEV标志物的细胞来源。
主要发现
- 发现阶段蛋白质组学显示,快速进展患者uEV中MMP-7蛋白丰度显著高于稳定疾病患者。
- 验证组中免疫印迹证实快速进展患者uEV-MMP-7显著增加>2倍。
- ELISA检测全尿中MMP-7无显著差异。
- 与健康肾脏组织相比,ADPKD组织近端小管和髓袢升支粗段细胞中MMP-7表达显著升高,并具有促纤维化表型。
临床怎么用
- uEV-MMP-7可能用于ADPKD患者快速进展的早期识别,辅助咨询和肾脏保护治疗的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: There is an unmet need for biomarkers of disease progression in autosomal dominant polycystic kidney disease (ADPKD). This study investigated urinary extracellular vesicles (uEVs) as a source of such biomarkers. Proteomic analysis of uEVs identified matrix metalloproteinase 7 (MMP-7) as a biomarker predictive of rapid disease progression. In validation studies, MMP-7 was predictive in uEVs but not in whole urine, possibly because uEVs are primarily secreted by tubular epithelial cells. Indeed, single-nucleus RNA sequencing showed that MMP-7 was especially increased in proximal tubule and thick ascending limb cells, which were further characterized by a profibrotic phenotype. Together, these data suggest that MMP-7 is a biologically plausible and promising uEV biomarker for rapid disease progression in ADPKD. BACKGROUND: In ADPKD, there is an unmet need for early markers of rapid disease progression to facilitate counseling and selection for kidney-protective therapy. Our aim was to identify markers for rapid disease progression in uEVs. METHODS: Six paired case-control groups ( n =10-59/group) of cases with rapid disease progression and controls with stable disease were formed from two independent ADPKD cohorts, with matching by age, sex, total kidney volume, and genetic variant. Candidate uEV biomarkers were identified by mass spectrometry and further analyzed using immunoblotting and an ELISA. Single-nucleus RNA sequencing of healthy and ADPKD tissue was used to identify the cellular origin of the uEV biomarker. RESULTS: In the discovery proteomics experiments, the protein abundance of MMP-7 was significantly higher in uEVs of patients with rapid disease progression compared with stable disease. In the validation groups, a significant >2-fold increase in uEV-MMP-7 in patients with rapid disease progression was confirmed using immunoblotting. By contrast, no significant difference in MMP-7 was found in whole urine using ELISA. Compared with healthy kidney tissue, ADPKD tissue had significantly higher MMP-7 expression in proximal tubule and thick ascending limb cells with a profibrotic phenotype. CONCLUSIONS: Among patients with ADPKD, rapid disease progressors have higher uEV-associated MMP-7. Our findings also suggest that MMP-7 is a biologically plausible biomarker for more rapid disease progression.
引用
- van Heugten MH, Blijdorp CJ, Arjune S, et al. Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2023. PMID: 38073039. doi:10.1681/ASN.0000000000000277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。